28355176|t|Visualization and targeting of LGR5(+) human colon cancer stem cells
28355176|a|The cancer stem cell (CSC) theory highlights a self-renewing subpopulation of cancer cells that fuels tumour growth. The existence of human CSCs is mainly supported by xenotransplantation of prospectively isolated cells, but their clonal dynamics and plasticity remain unclear. Here, we show that human LGR5(+) colorectal cancer cells serve as CSCs in growing cancer tissues. Lineage - tracing experiments with a tamoxifen -inducible Cre knock-in allele of LGR5 reveal the self-renewal and differentiation capacity of LGR5(+) tumour cells. Selective ablation of LGR5(+) CSCs in LGR5 -i Caspase9 knock-in organoids leads to tumour regression, followed by tumour regrowth driven by re-emerging LGR5(+) CSCs. KRT20 knock-in reporter marks differentiated cancer cells that constantly diminish in tumour tissues, while reverting to LGR5(+) CSCs and contributing to tumour regrowth after LGR5(+) CSC ablation. We also show that combined chemotherapy potentiates targeting of LGR5(+) CSCs. These data provide insights into the plasticity of CSCs and their potential as a therapeutic target in human colorectal cancer.
28355176	0	13	Visualization	T033	C0243095
28355176	18	27	targeting	T169	C1521840
28355176	31	38	LGR5(+)	T028	C1537570
28355176	39	44	human	T016	C0086418
28355176	45	50	colon	T023	C0009368
28355176	51	68	cancer stem cells	T025	C1956422
28355176	73	89	cancer stem cell	T025	C1956422
28355176	91	94	CSC	T025	C1956422
28355176	96	102	theory	T078	C0871935
28355176	116	129	self-renewing	T043	C4042950
28355176	130	143	subpopulation	T185	C0449560
28355176	147	159	cancer cells	T025	C0334227
28355176	171	185	tumour growth.	T191	C0598934
28355176	190	199	existence	T081	C1547035
28355176	203	208	human	T016	C0086418
28355176	209	213	CSCs	T025	C1956422
28355176	237	256	xenotransplantation	T061	C0520484
28355176	274	288	isolated cells	T033	C3829491
28355176	300	306	clonal	T024	C1522642
28355176	307	315	dynamics	T070	C3826426
28355176	320	330	plasticity	T070	C0678558
28355176	366	371	human	T016	C0086418
28355176	372	379	LGR5(+)	T028	C1537570
28355176	380	403	colorectal cancer cells	T025	C0334227
28355176	413	417	CSCs	T025	C1956422
28355176	429	435	cancer	T191	C0006826
28355176	436	443	tissues	T024	C0040300
28355176	445	452	Lineage	T077	C1881379
28355176	455	474	tracing experiments	T059	C0022885
28355176	482	491	tamoxifen	T109,T121	C0039286
28355176	503	506	Cre	T116,T126	C1744318
28355176	507	515	knock-in	T063	C2350597
28355176	516	522	allele	T028	C0002085
28355176	526	530	LGR5	T116,T192	C3640115
28355176	542	554	self-renewal	T043	C4042950
28355176	559	574	differentiation	T043	C0007589
28355176	575	583	capacity	T081	C1516240
28355176	587	594	LGR5(+)	T028	C1537570
28355176	595	607	tumour cells	T025	C0334227
28355176	619	627	ablation	T061	C0547070
28355176	631	638	LGR5(+)	T028	C1537570
28355176	639	643	CSCs	T025	C1956422
28355176	647	651	LGR5	T028	C1537570
28355176	655	663	Caspase9	T028	C1332668
28355176	664	672	knock-in	T063	C2350597
28355176	673	682	organoids	T024	C0029250
28355176	692	709	tumour regression	T201	C1718423
28355176	723	738	tumour regrowth	T191	C0598934
28355176	761	768	LGR5(+)	T028	C1537570
28355176	769	773	CSCs	T025	C1956422
28355176	775	780	KRT20	T028	C1426926
28355176	781	789	knock-in	T063	C2350597
28355176	790	798	reporter	T028	C0206414
28355176	805	819	differentiated	T043	C0007589
28355176	820	832	cancer cells	T025	C0334227
28355176	861	875	tumour tissues	T024	C0475358
28355176	896	903	LGR5(+)	T028	C1537570
28355176	904	908	CSCs	T025	C1956422
28355176	929	944	tumour regrowth	T191	C0598934
28355176	951	958	LGR5(+)	T028	C1537570
28355176	959	962	CSC	T025	C1956422
28355176	963	971	ablation	T061	C0547070
28355176	1000	1012	chemotherapy	T061	C3665472
28355176	1025	1034	targeting	T169	C1521840
28355176	1038	1045	LGR5(+)	T028	C1537570
28355176	1046	1050	CSCs	T025	C1956422
28355176	1058	1062	data	T078	C1511726
28355176	1089	1099	plasticity	T070	C0678558
28355176	1103	1107	CSCs	T025	C1956422
28355176	1118	1127	potential	T080	C3245505
28355176	1133	1144	therapeutic	T169	C0302350
28355176	1145	1151	target	T169	C1521840
28355176	1155	1160	human	T016	C0086418
28355176	1161	1178	colorectal cancer	T191	C1527249